Point72 Hong Kong LTD Catalent, Inc. Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $148,772 - $232,533	2,056 New	2,056 $149,000
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $1.02 Million - $1.17 Million	10,147 New	10,147 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $24,346 - $40,073	-507 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $18,733 - $31,915	507 New	507 $26,000
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $57,413 - $69,100	-1,220 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $86,928 - $106,347	-1,832 Reduced 60.03%	1,220 $58,000
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $119,821 - $165,448	3,052 New	3,052 $165,000
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $268 - $395	-9 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $269 - $417	9 New	9 $0
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $152,479 - $167,443	-3,938 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $154,723 - $186,100	3,927 Added 35700.0%	3,938 $162,000
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $409 - $473	11	11 $0

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.